Company intelligence / Profile preview

Mediclone Biotech

Chennai, Tamil Nadu, Indiamediclonebiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Mediclone has developed and commercialized a range of diagnostic kits based on monoclonal antibodies. The company is actively developing therapeutic biomolecules targeting infectious diseases and snake toxins, with ongoing R&D efforts but no published late-stage clinical results as of now.

Therapeutic areas: OtherHematologyInfectious Diseases
Modalities: Monoclonal antibodies (mAbs)Immunoserological kitsTherapeutic biologicals (including anti-rabies and anti-snake venom serum)
Industry: Biotech

Drug pipeline

3 assets

Anti-Rabies Biological

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

University of Madras (Postgraduate Diploma in Immunotechnology)Alagappa University (M.Sc. Biotechnology specialization in Immunotechnology)

Beyond the preview

Go deeper on Mediclone Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediclone Biotech.

Explore the full profile